RxDoctor Payments Data

Veronica Walker

Nurse Practitioner · Biloxi, MSNPI 1285287698

Payments from drug & device makers

$700in general payments, 2019–2025

Across 24 payments — averaging $29.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$348
  • Indivior Inc.$58
  • Valinor Pharma, LLC$49
  • Amgen$44
  • Forte Bio-pharma LLC$39
  • Scilex Pharmaceuticals Inc.$38
  • plus $123 from 5 others

What the payments were for

  • Food & beverage$700100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$700 in reported general payments places this provider in the 65th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$27,263
Medicare patients
179
Services billed
450

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen2,251$65,507
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl274$42,037
VraylarCariprazine Hcl22$33,286
MovantikNaloxegol Oxalate74$28,690
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,662$23,721
LinzessLinaclotide41$20,962
Gabapentin2,468$19,538
Lidocaine189$18,935
Diclofenac Sodium554$18,445
Oxycodone Hcl912$13,096
ZtlidoLidocaine24$12,049
Tizanidine Hcl1,388$8,190
Pregabalin820$7,194
SuboxoneBuprenorphine Hcl/Naloxone Hcl14$6,374
Celecoxib607$4,202

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar, Linzess$348$54,24863 claims
Scilex Pharmaceuticals Inc.Ztlido$38$12,04924 claims
Indivior Inc.Suboxone$58$6,37414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Biloxi

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →